QSAM Biosciences Clarifies Recent Promotional and Trading Activities at the Request of OTC Markets
February 11, 2021 18:08 ET
|
QSAM Biosciences Inc.
Austin, Texas;, Feb. 11, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM) (“QSAM” or the “Company”), today announced that it became aware on February 9, 2021 of certain promotional...
QSAM Biosciences Closes Series B Preferred Private Placement; $2.5 Million in New Capital to Fund Upcoming Clinical Trials
January 28, 2021 09:00 ET
|
QSAM Biosciences Inc.
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related diseases,...
QSAM Biosciences Receives Favorable Safety Results in Study for its Leading Radiopharmaceutical Drug Candidate
January 21, 2021 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Jan. 21, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines for the treatment of cancer and related diseases and...
QSAM Biosciences Receives Notice of Allowance for European Patent and Expands Licensed IP Portfolio
December 10, 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Dec. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next generation nuclear medicines, including Cyclosam® Samarium-153-DOTMP, for the...
QSAM Biosciences Issues Letter from New CEO; Presents Opportunities Ahead for Company
November 24, 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The recently appointed Chief Executive Officer of QSAM Biosciences Inc. (OTCQB: QSAM), Douglas Baum, provided in the following letter to...
QSAM Biosciences Advances Plan of Separation from Legacy Business
November 10, 2020 09:00 ET
|
QSAM Biosciences Inc.
Pharmaceutical Industry Experts Assume Leadership Roles at QSAM;Over $4M in Debt Eliminated from Balance Sheet Palm Beach, FL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM)...
QSAM Biosciences Starts Trading under New Symbol: QSAM
October 09, 2020 09:00 ET
|
QSAM Biosciences Inc.
Palm Beach, FL, Oct. 09, 2020 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM) announced today that it has commenced trading on The OTC Markets under the new stock symbol QSAM. The company’s...
Q2Earth Changes Name to QSAM Biosciences, Inc.; Will Commence Trading Under Symbol QSAM in 20 Business Days
September 10, 2020 09:00 ET
|
Q2Earth, Inc
Palm Beach, FL;, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Q2Earth Inc. (OTCQB: QPWRD) announced today that it has filed an amendment to its Certificate of Incorporation and has received FINRA approval to...
Q2Earth’s Bioscience Subsidiary, QSAM Therapeutics, Signs License for Promising Drug to Treat Bone Cancer
April 28, 2020 08:30 ET
|
Q2Earth, Inc
Palm Beach, FL, April 28, 2020 (GLOBE NEWSWIRE) -- Q2Earth, Inc. (OTCQB: QPWR) (the “Company” or “Q2”) announced today that its wholly-owned subsidiary, QSAM Therapeutics Inc. (“QSAM”), has signed...